Project: Developing and validating diagnostic tools for tight monitoring of Inflammatory Arthritis patients

We intend to develop diagnostic tools which allow Health Care Professionals (HCP) to monitor the status of inflammation and drug response in capillary blood of patients with Inflammatory Arthritis (I.A.) at the point-of-care. We will deliver a menu of fully quantitative lateral flow immunoassays to measure a) inflammation biomarkers, b) therapeutic drug concentrations, c) antibodies to therapeutic drugs, d) technology concepts for the simple and safe collection and processing of capillary blood.

Acronym opTIMISm (Reference Number: 10684)
Duration 01/10/2016 - 01/10/2019
Project Topic Biological Sciences / Technologies
Network Eurostars 2
Call Eurostars Cut-Off 5

Project partner

Number Name Role Country
24900 BÜHLMANN Laboratories AG Coordinator Switzerland
24901 Milenia Biotec GmbH Partner Germany
24902 Westfälische Wilhelms-Universität Münster - Universitätsklinikum Münster Partner Germany